avapro and Hyperlipemia
avapro has been researched along with Hyperlipemia in 4 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| " Risk factors for diabetic nephropathy are discussed, and include hyperglycemia, hypertension, angiotensin II, proteinuria, dyslipidemia, smoking, and anemia." | 4.82 | Outcome studies in diabetic nephropathy. ( Mohanram, A; Toto, RD, 2003) |
| " Therefore, we investigated whether endothelial dysfunction and/or vascular NO bioavailability is reflected by decreased vessel wall P-VASP and whether improvement of endothelial dysfunction restores this P-VASP." | 1.31 | Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction. ( Bodenschatz, M; Hoffmann, N; Meinertz, T; Mollnau, H; Münzel, T; Oelze, M; Skatchkov, M; Smolenski, A; Walter, U; Warnholtz, A, 2000) |
Research
Studies (4)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Zhao, Y | 1 |
| Fukao, K | 1 |
| Zhao, S | 1 |
| Watanabe, A | 1 |
| Hamada, T | 1 |
| Yamasaki, K | 1 |
| Shimizu, Y | 1 |
| Kubo, N | 1 |
| Ukon, N | 1 |
| Nakano, T | 1 |
| Tamaki, N | 1 |
| Kuge, Y | 1 |
| Rizos, CV | 1 |
| Milionis, HJ | 1 |
| Kostapanos, MS | 1 |
| Florentin, M | 1 |
| Kostara, CE | 1 |
| Elisaf, MS | 1 |
| Liberopoulos, EN | 1 |
| Mohanram, A | 1 |
| Toto, RD | 1 |
| Oelze, M | 1 |
| Mollnau, H | 1 |
| Hoffmann, N | 1 |
| Warnholtz, A | 1 |
| Bodenschatz, M | 1 |
| Smolenski, A | 1 |
| Walter, U | 1 |
| Skatchkov, M | 1 |
| Meinertz, T | 1 |
| Münzel, T | 1 |
Reviews
1 review available for avapro and Hyperlipemia
| Article | Year |
|---|---|
Outcome studies in diabetic nephropathy.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme | 2003 |
Trials
1 trial available for avapro and Hyperlipemia
| Article | Year |
|---|---|
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective study.
Topics: Aged; Antihypertensive Agents; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; C-React | 2010 |
Other Studies
2 other studies available for avapro and Hyperlipemia
| Article | Year |
|---|---|
Irbesartan attenuates atherosclerosis in Watanabe heritable hyperlipidemic rabbits: noninvasive imaging of inflammation by 18F-fluorodeoxyglucose positron emission tomography.
Topics: Animals; Antihypertensive Agents; Atherosclerosis; Autoradiography; Biphenyl Compounds; Body Weight; | 2015 |
Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta; Biphenyl Compounds; Cell | 2000 |